The Latest Cardiac and Vascular News
Seasoned MedTech executive to focus on therapy development initiatives as company continues to drive enrollment in DRAIN-HF pivotal IDE trial HOUSTON, Dec. 2, 2025 /PRNewswire/ — Procyrion™, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and…
Technology to be evaluated in acute decompensated heart failure patients, where current treatment options remain ineffective and lacking HOUSTON, Nov. 30, 2023 /PRNewswire/ — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal…
HOUSTON, Sept. 7, 2023 /PRNewswire/ — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today it has successfully secured new inpatient hospital ICD-10-PCS procedure codes applicable to its Aortix™ percutaneous mechanical circulatory support (pMCS) technology. The new codes represent a significant milestone as […]
Late-breaking data presented at THT shows substantial fluid loss and improvements in kidney and cardiac function at 30 days after Aortix therapy Cardiorenal syndrome (CRS) is a complex condition that impacts up to 40% of patients with acute decompensated heart failure and is growing at a double-digit rate HOUSTON, March 21, […]
A PRIORI study to evaluate safety and performance of novel Aortix percutaneous mechanical circulatory support device to increase renal perfusion Study adds to the growing body of data for the Aortix pump, which will be featured in a late-breaking presentation at the Technology and Heart Failure Therapeutics conference in March HOUSTON, Feb. […]
Pilot CRS Study to Evaluate Performance of Novel Aortix device in Australia and the U.S. HOUSTON, May 25, 2021 /PRNewswire/ — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the company’s pilot trial to evaluate […]
